Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875534 · ClinicalTrials.gov registry record
A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
A clinical trial, sponsored by Ascendis Pharma A/S.
- Completed
- Registry status
- 260
- Enrollment target
NCT03875534: Completed study, sponsored by Ascendis Pharma A/S.
NCT03875534 is a clinical trial that has completed, run by Ascendis Pharma A/S. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03875534 has completed, sponsored by Ascendis Pharma A/S.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.
Primary Outcome
Subjects will undergo a series of height measurements (in centimeters) on Day 1 and then every 6 months over the study period with height velocity reported in cm/year
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2019-06-19 |
| Est. Completion | 2024-01-12 |
What the finished NCT03875534 record still lists
NCT03875534 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03875534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03875534 about?
NCT03875534 is a clinical study titled "A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia". This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.
What is the current status of trial NCT03875534?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2019-06-19. Estimated completion is 2024-01-12.
Who is sponsoring clinical trial NCT03875534?
This trial is sponsored by Ascendis Pharma A/S, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI